CPBIO Holding Company Limited (HKG:3839)
7.92
-0.02 (-0.25%)
Oct 9, 2026, 3:56 PM HKT
CPBIO Holding Company Revenue
CPBIO Holding Company had revenue of $112.42M USD in the quarter ending June 30, 2026, a decrease of -28.98%. This brings the company's revenue in the last twelve months to $423.98M, down -18.95% year-over-year. In the year 2025, CPBIO Holding Company had annual revenue of $535.91M with 74.14% growth. That makes CPBIO Holding Company the 12,176th largest company in the world by revenue and 722nd in Hong Kong.
Revenue (ttm)
$423.98M
Revenue Growth
-18.95%
P/S Ratio
0.60
Revenue / Employee
$423.98K
Employees
1,000
Market Cap
2.01B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 535.91M | 228.17M | 74.14% |
| Dec 31, 2024 | 307.75M | 133.77M | 76.89% |
| Dec 31, 2023 | 173.98M | 14.74M | 9.26% |
| Dec 31, 2022 | 159.24M | 16.83M | 11.82% |
| Dec 31, 2021 | 142.41M | 48.83M | 52.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Edding Genor Group Holdings | 2.57B |
| Essex Bio-Technology | 1.72B |
| Jacobson Pharma Corporation | 1.57B |
| Dawnrays Pharmaceutical (Holdings) | 1.32B |
| Golden Throat Holdings Group Company | 1.04B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.04B |
| JBM (Healthcare) | 834.63M |
| Hua Medicine (Shanghai) | 755.49M |